# SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

> **NCT07422675** · PHASE1 · RECRUITING · sponsor: **Serina Therapeutics** · enrollment: 40 (estimated)

## Conditions studied

- PARKINSON DISEASE (Disorder)
- Advanced Parkinson's Disease

## Interventions

- **DRUG:** SER-252 (PEOZ-apomorphine)
- **DEVICE:** enFuse

## Key facts

- **NCT ID:** NCT07422675
- **Lead sponsor:** Serina Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422675, "SAD Study in Patients With Parkinson's Disease and Motor Fluctuations". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07422675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*